タファミディス・メグルミンのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Tafamidis Meglumine Market Insights, Forecast to 2028

• レポートコード：QY2207E02627 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、76ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のタファミディス・メグルミンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にタファミディス・メグルミンの世界市場のxxx％を占める「純度≥99%」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「製薬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のタファミディス・メグルミンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのタファミディス・メグルミン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのタファミディス・メグルミン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 タファミディス・メグルミンのグローバル主要メーカーには、SUANFARMA、Nuray Chemicals、Neuland Laboratories、Cangzhou Enke Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 タファミディス・メグルミン市場は、種類と用途によって区分されます。世界のタファミディス・メグルミン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 純度≥99%、純度≥99.5 【用途別セグメント】 製薬、研究用試薬、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - タファミディス・メグルミン製品概要 - 種類別市場（純度≥99%、純度≥99.5） - 用途別市場（製薬、研究用試薬、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のタファミディス・メグルミン販売量予測2017-2028 - 世界のタファミディス・メグルミン売上予測2017-2028 - タファミディス・メグルミンの地域別販売量 - タファミディス・メグルミンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別タファミディス・メグルミン販売量 - 主要メーカー別タファミディス・メグルミン売上 - 主要メーカー別タファミディス・メグルミン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（純度≥99%、純度≥99.5） - タファミディス・メグルミンの種類別販売量 - タファミディス・メグルミンの種類別売上 - タファミディス・メグルミンの種類別価格 ・用途別市場規模（製薬、研究用試薬、その他） - タファミディス・メグルミンの用途別販売量 - タファミディス・メグルミンの用途別売上 - タファミディス・メグルミンの用途別価格 ・北米市場 - 北米のタファミディス・メグルミン市場規模（種類別、用途別） - 主要国別のタファミディス・メグルミン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのタファミディス・メグルミン市場規模（種類別、用途別） - 主要国別のタファミディス・メグルミン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のタファミディス・メグルミン市場規模（種類別、用途別） - 主要国別のタファミディス・メグルミン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のタファミディス・メグルミン市場規模（種類別、用途別） - 主要国別のタファミディス・メグルミン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのタファミディス・メグルミン市場規模（種類別、用途別） - 主要国別のタファミディス・メグルミン市場規模（トルコ、サウジアラビア） ・企業情報 SUANFARMA、Nuray Chemicals、Neuland Laboratories、Cangzhou Enke Pharma ・産業チェーン及び販売チャネル分析 - タファミディス・メグルミンの産業チェーン分析 - タファミディス・メグルミンの原材料 - タファミディス・メグルミンの生産プロセス - タファミディス・メグルミンの販売及びマーケティング - タファミディス・メグルミンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - タファミディス・メグルミンの産業動向 - タファミディス・メグルミンのマーケットドライバー - タファミディス・メグルミンの課題 - タファミディス・メグルミンの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Tafamidis Meglumine Market
Due to the COVID-19 pandemic, the global Tafamidis Meglumine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Tafamidis Meglumine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
China Tafamidis Meglumine market size is valued at US$ million in 2021, while the US and Europe Tafamidis Meglumine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Tafamidis Meglumine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Tafamidis Meglumine include SUANFARMA, Nuray Chemicals, Neuland Laboratories and Cangzhou Enke Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Tafamidis Meglumine capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Tafamidis Meglumine by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Tafamidis Meglumine Scope and Segment
Tafamidis Meglumine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Tafamidis Meglumine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
Pharmaceutical
Research Reagents
Other
By Company
SUANFARMA
Nuray Chemicals
Neuland Laboratories
Cangzhou Enke Pharma
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Tafamidis Meglumine Product Introduction
1.2 Market by Type
1.2.1 Global Tafamidis Meglumine Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Market by Application
1.3.1 Global Tafamidis Meglumine Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical
1.3.3 Research Reagents
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Tafamidis Meglumine Production
2.1 Global Tafamidis Meglumine Production Capacity (2017-2028)
2.2 Global Tafamidis Meglumine Production by Region: 2017 VS 2021 VS 2028
2.3 Global Tafamidis Meglumine Production by Region
2.3.1 Global Tafamidis Meglumine Historic Production by Region (2017-2022)
2.3.2 Global Tafamidis Meglumine Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
3 Global Tafamidis Meglumine Sales in Volume & Value Estimates and Forecasts
3.1 Global Tafamidis Meglumine Sales Estimates and Forecasts 2017-2028
3.2 Global Tafamidis Meglumine Revenue Estimates and Forecasts 2017-2028
3.3 Global Tafamidis Meglumine Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Tafamidis Meglumine Sales by Region
3.4.1 Global Tafamidis Meglumine Sales by Region (2017-2022)
3.4.2 Global Sales Tafamidis Meglumine by Region (2023-2028)
3.5 Global Tafamidis Meglumine Revenue by Region
3.5.1 Global Tafamidis Meglumine Revenue by Region (2017-2022)
3.5.2 Global Tafamidis Meglumine Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Tafamidis Meglumine Production Capacity by Manufacturers
4.2 Global Tafamidis Meglumine Sales by Manufacturers
4.2.1 Global Tafamidis Meglumine Sales by Manufacturers (2017-2022)
4.2.2 Global Tafamidis Meglumine Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Tafamidis Meglumine in 2021
4.3 Global Tafamidis Meglumine Revenue by Manufacturers
4.3.1 Global Tafamidis Meglumine Revenue by Manufacturers (2017-2022)
4.3.2 Global Tafamidis Meglumine Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Tafamidis Meglumine Revenue in 2021
4.4 Global Tafamidis Meglumine Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Tafamidis Meglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Tafamidis Meglumine Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Tafamidis Meglumine Sales by Type
5.1.1 Global Tafamidis Meglumine Historical Sales by Type (2017-2022)
5.1.2 Global Tafamidis Meglumine Forecasted Sales by Type (2023-2028)
5.1.3 Global Tafamidis Meglumine Sales Market Share by Type (2017-2028)
5.2 Global Tafamidis Meglumine Revenue by Type
5.2.1 Global Tafamidis Meglumine Historical Revenue by Type (2017-2022)
5.2.2 Global Tafamidis Meglumine Forecasted Revenue by Type (2023-2028)
5.2.3 Global Tafamidis Meglumine Revenue Market Share by Type (2017-2028)
5.3 Global Tafamidis Meglumine Price by Type
5.3.1 Global Tafamidis Meglumine Price by Type (2017-2022)
5.3.2 Global Tafamidis Meglumine Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Tafamidis Meglumine Sales by Application
6.1.1 Global Tafamidis Meglumine Historical Sales by Application (2017-2022)
6.1.2 Global Tafamidis Meglumine Forecasted Sales by Application (2023-2028)
6.1.3 Global Tafamidis Meglumine Sales Market Share by Application (2017-2028)
6.2 Global Tafamidis Meglumine Revenue by Application
6.2.1 Global Tafamidis Meglumine Historical Revenue by Application (2017-2022)
6.2.2 Global Tafamidis Meglumine Forecasted Revenue by Application (2023-2028)
6.2.3 Global Tafamidis Meglumine Revenue Market Share by Application (2017-2028)
6.3 Global Tafamidis Meglumine Price by Application
6.3.1 Global Tafamidis Meglumine Price by Application (2017-2022)
6.3.2 Global Tafamidis Meglumine Price Forecast by Application (2023-2028)
7 North America
7.1 North America Tafamidis Meglumine Market Size by Type
7.1.1 North America Tafamidis Meglumine Sales by Type (2017-2028)
7.1.2 North America Tafamidis Meglumine Revenue by Type (2017-2028)
7.2 North America Tafamidis Meglumine Market Size by Application
7.2.1 North America Tafamidis Meglumine Sales by Application (2017-2028)
7.2.2 North America Tafamidis Meglumine Revenue by Application (2017-2028)
7.3 North America Tafamidis Meglumine Sales by Country
7.3.1 North America Tafamidis Meglumine Sales by Country (2017-2028)
7.3.2 North America Tafamidis Meglumine Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Tafamidis Meglumine Market Size by Type
8.1.1 Europe Tafamidis Meglumine Sales by Type (2017-2028)
8.1.2 Europe Tafamidis Meglumine Revenue by Type (2017-2028)
8.2 Europe Tafamidis Meglumine Market Size by Application
8.2.1 Europe Tafamidis Meglumine Sales by Application (2017-2028)
8.2.2 Europe Tafamidis Meglumine Revenue by Application (2017-2028)
8.3 Europe Tafamidis Meglumine Sales by Country
8.3.1 Europe Tafamidis Meglumine Sales by Country (2017-2028)
8.3.2 Europe Tafamidis Meglumine Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Tafamidis Meglumine Market Size by Type
9.1.1 Asia Pacific Tafamidis Meglumine Sales by Type (2017-2028)
9.1.2 Asia Pacific Tafamidis Meglumine Revenue by Type (2017-2028)
9.2 Asia Pacific Tafamidis Meglumine Market Size by Application
9.2.1 Asia Pacific Tafamidis Meglumine Sales by Application (2017-2028)
9.2.2 Asia Pacific Tafamidis Meglumine Revenue by Application (2017-2028)
9.3 Asia Pacific Tafamidis Meglumine Sales by Region
9.3.1 Asia Pacific Tafamidis Meglumine Sales by Region (2017-2028)
9.3.2 Asia Pacific Tafamidis Meglumine Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Tafamidis Meglumine Market Size by Type
10.1.1 Latin America Tafamidis Meglumine Sales by Type (2017-2028)
10.1.2 Latin America Tafamidis Meglumine Revenue by Type (2017-2028)
10.2 Latin America Tafamidis Meglumine Market Size by Application
10.2.1 Latin America Tafamidis Meglumine Sales by Application (2017-2028)
10.2.2 Latin America Tafamidis Meglumine Revenue by Application (2017-2028)
10.3 Latin America Tafamidis Meglumine Sales by Country
10.3.1 Latin America Tafamidis Meglumine Sales by Country (2017-2028)
10.3.2 Latin America Tafamidis Meglumine Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Tafamidis Meglumine Market Size by Type
11.1.1 Middle East and Africa Tafamidis Meglumine Sales by Type (2017-2028)
11.1.2 Middle East and Africa Tafamidis Meglumine Revenue by Type (2017-2028)
11.2 Middle East and Africa Tafamidis Meglumine Market Size by Application
11.2.1 Middle East and Africa Tafamidis Meglumine Sales by Application (2017-2028)
11.2.2 Middle East and Africa Tafamidis Meglumine Revenue by Application (2017-2028)
11.3 Middle East and Africa Tafamidis Meglumine Sales by Country
11.3.1 Middle East and Africa Tafamidis Meglumine Sales by Country (2017-2028)
11.3.2 Middle East and Africa Tafamidis Meglumine Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 SUANFARMA
12.1.1 SUANFARMA Corporation Information
12.1.2 SUANFARMA Overview
12.1.3 SUANFARMA Tafamidis Meglumine Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 SUANFARMA Tafamidis Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 SUANFARMA Recent Developments
12.2 Nuray Chemicals
12.2.1 Nuray Chemicals Corporation Information
12.2.2 Nuray Chemicals Overview
12.2.3 Nuray Chemicals Tafamidis Meglumine Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Nuray Chemicals Tafamidis Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Nuray Chemicals Recent Developments
12.3 Neuland Laboratories
12.3.1 Neuland Laboratories Corporation Information
12.3.2 Neuland Laboratories Overview
12.3.3 Neuland Laboratories Tafamidis Meglumine Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Neuland Laboratories Tafamidis Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Neuland Laboratories Recent Developments
12.4 Cangzhou Enke Pharma
12.4.1 Cangzhou Enke Pharma Corporation Information
12.4.2 Cangzhou Enke Pharma Overview
12.4.3 Cangzhou Enke Pharma Tafamidis Meglumine Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Cangzhou Enke Pharma Tafamidis Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Cangzhou Enke Pharma Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Tafamidis Meglumine Industry Chain Analysis
13.2 Tafamidis Meglumine Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Tafamidis Meglumine Production Mode & Process
13.4 Tafamidis Meglumine Sales and Marketing
13.4.1 Tafamidis Meglumine Sales Channels
13.4.2 Tafamidis Meglumine Distributors
13.5 Tafamidis Meglumine Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Tafamidis Meglumine Industry Trends
14.2 Tafamidis Meglumine Market Drivers
14.3 Tafamidis Meglumine Market Challenges
14.4 Tafamidis Meglumine Market Restraints
15 Key Finding in The Global Tafamidis Meglumine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Tafamidis Meglumine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity ≥99%
Table 3. Major Manufacturers of Purity ≥99.5%
Table 4. Global Tafamidis Meglumine Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Tafamidis Meglumine Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Tafamidis Meglumine Production by Region (2017-2022) & (Tons)
Table 7. Global Tafamidis Meglumine Production Market Share by Region (2017-2022)
Table 8. Global Tafamidis Meglumine Production by Region (2023-2028) & (Tons)
Table 9. Global Tafamidis Meglumine Production Market Share by Region (2023-2028)
Table 10. Global Tafamidis Meglumine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Tafamidis Meglumine Sales by Region (2017-2022) & (Tons)
Table 12. Global Tafamidis Meglumine Sales Market Share by Region (2017-2022)
Table 13. Global Tafamidis Meglumine Sales by Region (2023-2028) & (Tons)
Table 14. Global Tafamidis Meglumine Sales Market Share by Region (2023-2028)
Table 15. Global Tafamidis Meglumine Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Tafamidis Meglumine Revenue Market Share by Region (2017-2022)
Table 17. Global Tafamidis Meglumine Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Tafamidis Meglumine Revenue Market Share by Region (2023-2028)
Table 19. Global Tafamidis Meglumine Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Tafamidis Meglumine Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Tafamidis Meglumine Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Tafamidis Meglumine Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Tafamidis Meglumine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Tafamidis Meglumine Revenue Share by Manufacturers (2017-2022)
Table 25. Tafamidis Meglumine Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Tafamidis Meglumine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Tafamidis Meglumine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tafamidis Meglumine as of 2021)
Table 28. Tafamidis Meglumine Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Tafamidis Meglumine Product Offered
Table 30. Date of Manufacturers Enter into Tafamidis Meglumine Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Tafamidis Meglumine Sales by Type (2017-2022) & (Tons)
Table 33. Global Tafamidis Meglumine Sales by Type (2023-2028) & (Tons)
Table 34. Global Tafamidis Meglumine Sales Share by Type (2017-2022)
Table 35. Global Tafamidis Meglumine Sales Share by Type (2023-2028)
Table 36. Global Tafamidis Meglumine Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Tafamidis Meglumine Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Tafamidis Meglumine Revenue Share by Type (2017-2022)
Table 39. Global Tafamidis Meglumine Revenue Share by Type (2023-2028)
Table 40. Tafamidis Meglumine Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Tafamidis Meglumine Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Tafamidis Meglumine Sales by Application (2017-2022) & (Tons)
Table 43. Global Tafamidis Meglumine Sales by Application (2023-2028) & (Tons)
Table 44. Global Tafamidis Meglumine Sales Share by Application (2017-2022)
Table 45. Global Tafamidis Meglumine Sales Share by Application (2023-2028)
Table 46. Global Tafamidis Meglumine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Tafamidis Meglumine Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Tafamidis Meglumine Revenue Share by Application (2017-2022)
Table 49. Global Tafamidis Meglumine Revenue Share by Application (2023-2028)
Table 50. Tafamidis Meglumine Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Tafamidis Meglumine Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Tafamidis Meglumine Sales by Type (2017-2022) & (Tons)
Table 53. North America Tafamidis Meglumine Sales by Type (2023-2028) & (Tons)
Table 54. North America Tafamidis Meglumine Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Tafamidis Meglumine Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Tafamidis Meglumine Sales by Application (2017-2022) & (Tons)
Table 57. North America Tafamidis Meglumine Sales by Application (2023-2028) & (Tons)
Table 58. North America Tafamidis Meglumine Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Tafamidis Meglumine Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Tafamidis Meglumine Sales by Country (2017-2022) & (Tons)
Table 61. North America Tafamidis Meglumine Sales by Country (2023-2028) & (Tons)
Table 62. North America Tafamidis Meglumine Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Tafamidis Meglumine Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Tafamidis Meglumine Sales by Type (2017-2022) & (Tons)
Table 65. Europe Tafamidis Meglumine Sales by Type (2023-2028) & (Tons)
Table 66. Europe Tafamidis Meglumine Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Tafamidis Meglumine Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Tafamidis Meglumine Sales by Application (2017-2022) & (Tons)
Table 69. Europe Tafamidis Meglumine Sales by Application (2023-2028) & (Tons)
Table 70. Europe Tafamidis Meglumine Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Tafamidis Meglumine Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Tafamidis Meglumine Sales by Country (2017-2022) & (Tons)
Table 73. Europe Tafamidis Meglumine Sales by Country (2023-2028) & (Tons)
Table 74. Europe Tafamidis Meglumine Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Tafamidis Meglumine Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Tafamidis Meglumine Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Tafamidis Meglumine Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Tafamidis Meglumine Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Tafamidis Meglumine Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Tafamidis Meglumine Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Tafamidis Meglumine Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Tafamidis Meglumine Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Tafamidis Meglumine Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Tafamidis Meglumine Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Tafamidis Meglumine Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Tafamidis Meglumine Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Tafamidis Meglumine Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Tafamidis Meglumine Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Tafamidis Meglumine Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Tafamidis Meglumine Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Tafamidis Meglumine Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Tafamidis Meglumine Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Tafamidis Meglumine Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Tafamidis Meglumine Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Tafamidis Meglumine Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Tafamidis Meglumine Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Tafamidis Meglumine Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Tafamidis Meglumine Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Tafamidis Meglumine Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Tafamidis Meglumine Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Tafamidis Meglumine Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Tafamidis Meglumine Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Tafamidis Meglumine Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Tafamidis Meglumine Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Tafamidis Meglumine Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Tafamidis Meglumine Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Tafamidis Meglumine Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Tafamidis Meglumine Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Tafamidis Meglumine Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Tafamidis Meglumine Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Tafamidis Meglumine Revenue by Country (2023-2028) & (US$ Million)
Table 112. SUANFARMA Corporation Information
Table 113. SUANFARMA Description and Major Businesses
Table 114. SUANFARMA Tafamidis Meglumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. SUANFARMA Tafamidis Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. SUANFARMA Recent Development
Table 117. Nuray Chemicals Corporation Information
Table 118. Nuray Chemicals Description and Major Businesses
Table 119. Nuray Chemicals Tafamidis Meglumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Nuray Chemicals Tafamidis Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Nuray Chemicals Recent Development
Table 122. Neuland Laboratories Corporation Information
Table 123. Neuland Laboratories Description and Major Businesses
Table 124. Neuland Laboratories Tafamidis Meglumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Neuland Laboratories Tafamidis Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Neuland Laboratories Recent Development
Table 127. Cangzhou Enke Pharma Corporation Information
Table 128. Cangzhou Enke Pharma Description and Major Businesses
Table 129. Cangzhou Enke Pharma Tafamidis Meglumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Cangzhou Enke Pharma Tafamidis Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Cangzhou Enke Pharma Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Tafamidis Meglumine Distributors List
Table 135. Tafamidis Meglumine Customers List
Table 136. Tafamidis Meglumine Market Trends
Table 137. Tafamidis Meglumine Market Drivers
Table 138. Tafamidis Meglumine Market Challenges
Table 139. Tafamidis Meglumine Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Tafamidis Meglumine Product Picture
Figure 2. Global Tafamidis Meglumine Market Share by Type in 2021 & 2028
Figure 3. Purity ≥99% Product Picture
Figure 4. Purity ≥99.5% Product Picture
Figure 5. Global Tafamidis Meglumine Market Share by Application in 2021 & 2028
Figure 6. Pharmaceutical
Figure 7. Research Reagents
Figure 8. Other
Figure 9. Tafamidis Meglumine Report Years Considered
Figure 10. Global Tafamidis Meglumine Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global Tafamidis Meglumine Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Tafamidis Meglumine Production Market Share by Region (2017-2022)
Figure 13. Global Tafamidis Meglumine Production Market Share by Region (2023-2028)
Figure 14. Tafamidis Meglumine Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. Tafamidis Meglumine Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. Tafamidis Meglumine Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. Tafamidis Meglumine Production Growth Rate in India (2017-2028) & (Tons)
Figure 18. Global Tafamidis Meglumine Sales 2017-2028 (Tons)
Figure 19. Global Tafamidis Meglumine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Tafamidis Meglumine Revenue 2017-2028 (US$ Million)
Figure 21. Global Tafamidis Meglumine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Tafamidis Meglumine Sales Market Share by Region (2017-2022)
Figure 23. Global Tafamidis Meglumine Sales Market Share by Region (2023-2028)
Figure 24. North America Tafamidis Meglumine Sales YoY (2017-2028) & (Tons)
Figure 25. North America Tafamidis Meglumine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Tafamidis Meglumine Sales YoY (2017-2028) & (Tons)
Figure 27. Europe Tafamidis Meglumine Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Tafamidis Meglumine Sales YoY (2017-2028) & (Tons)
Figure 29. Asia-Pacific Tafamidis Meglumine Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Tafamidis Meglumine Sales YoY (2017-2028) & (Tons)
Figure 31. Latin America Tafamidis Meglumine Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Tafamidis Meglumine Sales YoY (2017-2028) & (Tons)
Figure 33. Middle East & Africa Tafamidis Meglumine Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Tafamidis Meglumine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Tafamidis Meglumine in the World: Market Share by Tafamidis Meglumine Revenue in 2021
Figure 36. Tafamidis Meglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Tafamidis Meglumine Sales Market Share by Type (2017-2028)
Figure 38. Global Tafamidis Meglumine Revenue Market Share by Type (2017-2028)
Figure 39. Global Tafamidis Meglumine Sales Market Share by Application (2017-2028)
Figure 40. Global Tafamidis Meglumine Revenue Market Share by Application (2017-2028)
Figure 41. North America Tafamidis Meglumine Sales Market Share by Type (2017-2028)
Figure 42. North America Tafamidis Meglumine Revenue Market Share by Type (2017-2028)
Figure 43. North America Tafamidis Meglumine Sales Market Share by Application (2017-2028)
Figure 44. North America Tafamidis Meglumine Revenue Market Share by Application (2017-2028)
Figure 45. North America Tafamidis Meglumine Sales Share by Country (2017-2028)
Figure 46. North America Tafamidis Meglumine Revenue Share by Country (2017-2028)
Figure 47. United States Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Tafamidis Meglumine Sales Market Share by Type (2017-2028)
Figure 50. Europe Tafamidis Meglumine Revenue Market Share by Type (2017-2028)
Figure 51. Europe Tafamidis Meglumine Sales Market Share by Application (2017-2028)
Figure 52. Europe Tafamidis Meglumine Revenue Market Share by Application (2017-2028)
Figure 53. Europe Tafamidis Meglumine Sales Share by Country (2017-2028)
Figure 54. Europe Tafamidis Meglumine Revenue Share by Country (2017-2028)
Figure 55. Germany Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 56. France Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Tafamidis Meglumine Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific Tafamidis Meglumine Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific Tafamidis Meglumine Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Tafamidis Meglumine Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Tafamidis Meglumine Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Tafamidis Meglumine Revenue Share by Region (2017-2028)
Figure 66. China Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 69. India Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 71. China Taiwan Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America Tafamidis Meglumine Sales Market Share by Type (2017-2028)
Figure 76. Latin America Tafamidis Meglumine Revenue Market Share by Type (2017-2028)
Figure 77. Latin America Tafamidis Meglumine Sales Market Share by Application (2017-2028)
Figure 78. Latin America Tafamidis Meglumine Revenue Market Share by Application (2017-2028)
Figure 79. Latin America Tafamidis Meglumine Sales Share by Country (2017-2028)
Figure 80. Latin America Tafamidis Meglumine Revenue Share by Country (2017-2028)
Figure 81. Mexico Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 84. Colombia Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 85. Middle East and Africa Tafamidis Meglumine Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Tafamidis Meglumine Revenue Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Tafamidis Meglumine Sales Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Tafamidis Meglumine Revenue Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Tafamidis Meglumine Sales Share by Country (2017-2028)
Figure 90. Middle East and Africa Tafamidis Meglumine Revenue Share by Country (2017-2028)
Figure 91. Turkey Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 92. Saudi Arabia Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 93. UAE Tafamidis Meglumine Revenue (2017-2028) & (US$ Million)
Figure 94. Tafamidis Meglumine Value Chain
Figure 95. Tafamidis Meglumine Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed

---